Wellington Management Group LLP Innate Pharma Sa Transaction History

Wellington Management Group LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.09 - $4.83 $5.46 Million - $6.45 Million	-1,334,652 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$3.85 - $5.62 $84,488 - $123,330	-21,945 Reduced 1.62%	1,334,652 $5.46 Million
Q3 2020 Nov 16, 2020	BUY	$3.77 - $6.55 $19,072 - $33,136	5,059 Added 0.37%	1,356,597 $5.39 Million
Q2 2020 Aug 14, 2020	BUY	$5.36 - $8.2 $93,414 - $142,909	17,428 Added 1.31%	1,351,538 $9.87 Million
Q1 2020 May 14, 2020	SELL	$3.8 - $7.95 $74,719 - $156,320	-19,663 Reduced 1.45%	1,334,110 $8.91 Million
Q4 2019 Feb 11, 2020	BUY	$5.66 - $6.55 $7.66 Million - $8.87 Million	1,353,773 New	1,353,773 $8.71 Million

238K

Ticker IPHA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,893,000
Market Cap $141M
Description
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.